MedPath

POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE

POLYMYXIN B SULFATE and TRIMETHOPRIM

Approved
Approval ID

0461401a-17c1-460f-b9ec-ff1cfe514f57

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 3, 2012

Manufacturers
FDA

H.J. Harkins Company, Inc.

DUNS: 147681894

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

polymyxin B sulfate, trimethoprim sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52959-609
Application NumberNDA050567
Product Classification
M
Marketing Category
C73605
G
Generic Name
polymyxin B sulfate, trimethoprim sulfate
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateJanuary 3, 2012
FDA Product Classification

INGREDIENTS (7)

polymyxin B sulfateActive
Quantity: 10000 [USP'U] in 1 mL
Code: 19371312D4
Classification: ACTIB
waterInactive
Code: 059QF0KO0R
Classification: IACT
sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
benzalkonium chlorideInactive
Code: F5UM2KM3W7
Classification: IACT
sulfuric acidInactive
Code: O40UQP6WCF
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
trimethoprim sulfateActive
Quantity: 1 mg in 1 mL
Code: E377MF8EQ8
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE - FDA Drug Approval Details